Novel insights into NOD-like receptors in renal diseases

被引：0
作者：
Juan Jin
Tao-jie Zhou
Gui-ling Ren
Liang Cai
Xiao-ming Meng
机构：
[1] Inflammation and Immune Mediated Diseases Laboratory of Anhui Province,Department of Pharmacy
[2] Anhui Institute of Innovative Drugs,undefined
[3] School of Pharmacy,undefined
[4] Anhui Medical University,undefined
[5] The Key Laboratory of Anti-Inflammatory of Immune Medicines,undefined
[6] Ministry of Education,undefined
[7] School of Basic Medicine,undefined
[8] Anhui Medical University,undefined
[9] Second Clinical Medical College,undefined
[10] Anhui Medical University,undefined
[11] The 901 Hospital of Chinese People’s Liberation Army Joint Service Support Unit,undefined
来源：
Acta Pharmacologica Sinica | 2022年 / 43卷
关键词：
NOD-like receptors; innate immunity; inflammasome; renal disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nucleotide-binding oligomerization domain-like receptors (NLRs), including NLRAs, NLRBs (also known as NAIPs), NLRCs, and NLRPs, are a major subfamily of pattern recognition receptors (PRRs). Owing to a recent surge in research, NLRs have gained considerable attention due to their involvement in mediating the innate immune response and perpetuating inflammatory pathways, which is a central phenomenon in the pathogenesis of multiple diseases, including renal diseases. NLRs are expressed in different renal tissues during pathological conditions, which suggest that these receptors play roles in acute kidney injury, obstructive nephropathy, diabetic nephropathy, IgA nephropathy, lupus nephritis, crystal nephropathy, uric acid nephropathy, and renal cell carcinoma, among others. This review summarises recent progress on the functions of NLRs and their mechanisms in the pathophysiological processes of different types of renal diseases to help us better understand the role of NLRs in the kidney and provide a theoretical basis for NLR-targeted therapy for renal diseases.
引用
收藏
页码：2789 / 2806
页数：17
相关论文
共 1285 条
[41]  
Viala J(2021)NLRC5 deficiency protects against acute kidney injury in mice by mediating carcinoembryonic antigen-related cell adhesion molecule 1 signaling Immunology. 162 249-20
[42]  
Chamaillard M(1994)Enigmatic inflammasomes. Science. 265 106-8
[43]  
Labigne A(2012)Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA Nat Immunol 13 823-44
[44]  
Thomas G(2018)The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-κB Immunity. 49 1049-23
[45]  
Girardin SE(2014)The innate immune sensor NLRC3 acts as a rheostat that fine-tunes T cell responses in infection and autoimmunity Immunity. 40 329-25
[46]  
Boneca IG(2012)NLRC3, a member of the NLR family of proteins, is a negative regulator of innate immune signaling induced by the DNA sensor STING Nature 488 389-8
[47]  
Carneiro LA(2017)NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens J Exp Med 214 2405-93
[48]  
Antignac A(2009)NLRX1 dampens oxidative stress and apoptosis in tissue injury via control of mitochondrial activity J Cell Sci 122 3161-71
[49]  
Jéhanno M(2014)An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix Mol Brain 7 1732-48
[50]  
Viala J(2010)Nlrx1 regulates neuronal cell death J Am Soc Nephrol 21 1512-22
12345678910